Treatment Journey With CAR T-Cell Therapy: Recommendations for Care Teams, Patients, and Caregivers

Experts discuss key information and roles for nurses in managing patients who have been treated with CAR T-cell therapy, including key elements for education along the treatment journey and management of related toxicities.
Alix Beaupierre, BSN, RN, OCN
person default
Kathleen McDermott, RN, BSN, OCN, BMTCN

Downloadable PDF

Download this PDF summarizing key considerations for nurses who manage patients being treated with CAR T-cell therapy.

Alix Beaupierre, BSN, RN, OCN person default Kathleen McDermott, RN, BSN, OCN, BMTCN Released: May 19, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from
Celgene Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?